Wednesday, Minimed Group, Inc (MMED), a medical technology company, reported a wider loss for the fourth quarter of 2026, ending April 24, despite higher revenue.
Net loss attributable to the company was $183 million, in comparison with the $172 million in the same quarter last year.
On the Nasdaq, the pre-market shares were down 4.72 percent at $12.88, after closing Tuesday's regular trading 2.50 percent higher.
The loss per share for the fourth quarter was $0.68, same as last year.
Revenue for the fourth quarter rose to $837 million, from $724 million in the same quarter in the prior year.
Looking forward for the fiscal 2027, the company expects organic revenue growth of around 10 percent, including a 1.0 to 1.5 percent expected benefit from the extra week in full year 2027. It also expects Adjusted EBITDA Margin of approximately 16 percent.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.